One major function of the hypothalamus is to maintain homeostasis by modulating the secretion of pituitary hormones. The paraventricular (PVN) and supraoptic (SON) nuclei are major integration centers for the output of the hypothalamus to the pituitary. The bHLH±PAS transcription factor SIM1 is crucial for the development of several neuroendocrine lineages within the PVN and SON. bHLH±PAS proteins require heterodimerization for their function. ARNT, ARNT2, and BMAL1 are the three known general heterodimerization partners for bHLH±PAS proteins. Here, we provide evidence that Sim1 and Arnt2 form dimers in vitro, that they are co-expressed in the PVN and SON, and that their loss of function affects the development of the same sets of neuroendocrine cell types within the PVN and SON. Together, these results implicate ARNT2 as the in vivo dimerization partner of SIM1 in controlling the development of these neuroendocrine lineages. q
Introduction
The transcription factor SIM1 is a critical regulator of neuronal differentiation. In mice, several neuronal lineages located within three nuclei of the hypothalamus, the paraventricular (PVN), the anterior periventricular (aPV) and the supraoptic (SON) nuclei fail to develop in the absence of Sim1 gene function (Michaud et al., 1998) . These nuclei are major components of the hypothalamic-pituitary axis (Swanson and Sawchenko, 1983; Swanson, 1986; Sawchenko et al., 1992) . The PVN and SON contain magnocellular neurons which project their axons to the posterior pituitary where they secrete vasopressin (AVP) and oxytocin (OT). In addition, the PVN and the ventrally contiguous aPV contain parvocellular neurons which project their axons to the median eminence where they secrete the corticotropin-releasing hormone (CRH), the thyroptropin-releasing hormone (TRH) and somatostatin (SS, mainly expressed in the aPV). These peptides are carried by the portal vasculature to the anterior pituitary where they modulate the secretion of a series of pituitary hormones. The entire magnocellular neurosecretory system, de®ned by the expression of AVP and OT, and at least three parvocellular lineages identi®ed respectively by the production of TRH, CRH and SS fail to develop in the hypothalamus of Sim1 mutant mice.
SIM1 is a member of an emerging family of transcription factors characterized by the presence of bHLH (basic helixloop-helix) and PAS (for Per, ARNT and Sim, the ®rst proteins shown to contain this motif) domains Fan et al., 1996) . Close relatives of SIM1 include CLOCK, which participates in the control of circadian rhythms (King et al., 1997) , hypoxia-inducible factor-1a (HIF-1a) and endothelial PAS domain protein 1 (EPAS1) which regulate the response to hypoxia (Wang et al., 1995; Ema et al., 1997; Tian et al., 1997) and the arylhydrocarbon receptor (AHR) which mediates the effects of dioxin (Burbach et al., 1992) . These bHLH±PAS factors form a group of proteins that do not homodimerize but heterodimerize with members of another group of bHLH±PAS proteins, for which there are only three representatives yet described: ARNT (Hoffman et al., 1991) , ARNT2 (Hirose et al., 1996) and BMAL1 (Hogenesch et al., 1997; Ikeda and Nomura, 1997; Takahata et al., 1998; Wolting et al., 1998) . For instance, CLOCK appears to dimerize with BMAL1 to control circadian gene expression (Gekakis et al., 1998; Jin et al., 1999) whereas HIF-1a most likely dimerizes with ARNT to mediate response to hypoxia (Maltepe et al., 1997; Iyer et al., 1998) . Because of its general expression within the CNS (Jain et al., 1998) , Arnt2 is thought to compensate for low levels of Arnt within the CNS to mediate hypoxia response (Iyer et al., 1998) . All three genes are documented to be expressed within the brain but with little detail concerning their PVN/SON expression. It is therefore not known which of these potential partners is required for SIM1 function during PVN/SON development. Using co-immunoprecipitation assays, expression studies and mutant analysis, we provide evidence here that ARNT2 is the in vivo dimerization partner of SIM1 during development of the PVN/SON.
Material and methods

In vitro translation and immunoprecipitation
SIM1-HA, ARNT, ARNT2, BMAL1, and MYF5 were translated in the reticulocyte lysate in the presence of [ 35 S]methionine (Amersham) or unlabeled methionine following the manufacturer's recommendations (TNT/T7 kit, Promega). Due to different methionine content, translation ef®ciency and multiple translation products of each protein, equal molar amount rather than equal volume of the major translation products were included in each reaction after resolving the products by SDS-PAGE and quantifying them by Phosphor-imager or densitometry. Although varied between each translation, typically about 1.25 ml of SIM1-HA (for the unlabeled and the 35 S-labeled), 2 ml of ARNT, 0.7 ml of ARNT2, 12 ml of BMAL1 and 25 ml of MYF5 translation products were used for each reaction. Protein samples were treated with RNaseA, DNaseI, and ethidium bromide to prevent non-speci®c precipitation with nucleic acids and spun for 30 min in the microfuge prior to co-incubation. Samples were combined as indicated in the text and incubated at 378C for 30 min and room temperature for 1 h to allow dimer formation. 0.25 ml of NP40-lysis buffer (25 mM Tris±HCl (pH 7.5), 150 mM NaCl, and 1% NP40) containing 1 mg of the 12CA5 anti-HA monoclonal Ab (BABCO) were added and incubated for 1 h, and then 10 ml of protein A beads were included and incubated for 1 h. The beads were washed for ®ve times in 1 ml of NP40-lysis buffer and collected by centrifugation. The protein samples were released from the beads in the SDSsample buffer and boiled for 3 min before loading and resolved by a 9% SDS-PAGE.
Mice
The c 112K mice were derived at the Oak Ridge National Laboratory (Russell et al., 1979 (Russell et al., , 1982 . The c 3H mice originated at Harwell (Dr Searle). The albino (c) deletions were maintained as heterozygotes over a chinchila (c ch ) mutation at the c locus. For details, see Wines et al. (1998) . For both of these deletions, the homozygous embryos were distinguished from their wild-type and heterozygous littermates by the lack of eye pigmentation. The wild-type and heterozygous embryos were not distinguishable by their pigmentation and were used interchangeably as controls in the text and ®gures. The Sim1 mice were generated and genotyped as previously described (Michaud et al., 1998) . This mutation was maintained on a mixed C57BL/6-129/Sv background.
Histology, immunohistochemistry and in situ hybridization
For histology, newborn brains were ®xed in Bouin's¯uid, embedded in paraf®n and sectioned coronally at 6 mm. Sections were stained with hematoxylin. Immunohistochemistry was performed as previously described (Michaud et al., 1998) using antibodies against AVP, OT and SS (Peninsula Labs). In situ hybridization on paraf®n sections was performed as previously described (Michaud et al., 1998) . The Crh, Arnt and Bmal1 probes were graciously provided by Drs A.F. Seasholtz (Seasholtz et al., 1991) , Y. Fujii-Kuriyama and Charles Weitz (Gekakis et al., 1998) , respectively. The Brn2 and Trh probes have been previously described (Michaud et al., 1998) . The Arnt2 probe was generated by RT-PCR, using total RNA isolated from mouse newborn hypothalamus. The sequence of the primers used to amplify Arnt2 is as follows:
Results
SIM1 can heterodimerize with all three potential partners
It has been previously shown that SIM1 can interact with either ARNT or ARNT2 in a yeast two-hybrid system . Although the interaction between SIM1 and ARNT has been con®rmed by biochemical studies Probst et al., 1997) , such interaction has not been con®rmed for SIM1 and ARNT2 and no data were available concerning the binding of SIM1 to BMAL1. In order to systematically evaluate the interaction between SIM1 and its potential dimerization partners, we performed a coimmunoprecipitation assay using in vitro translated HAtagged SIM1 protein in combination with ARNT, ARNT2, BMAL1 or MYF5, a bHLH transcription factor lacking a PAS domain (Fig. 1A) . When translated and incubated alone, SIM1-HA but not ARNT, ARNT2, BMAL1, nor MYF5 were immunoprecipitated by the anti-HA monoclonal antibody 12CA5. When combined with SIM1-HA, all three partners but not MYF5 were co-precipitated by the anti-HA antibody (n $ 4). These results indicate that SIM1 can form stable dimers with all three potential partners in vitro.
Sim1 and Arnt2 are co-expressed in the developing PVN/SON
The biochemical interactions between SIM1 and the three ARNT-related proteins do not indicate which is the in vivo partner of SIM1 in the hypothalamus. To determine which of these proteins may be the in vivo functional partner of SIM1 in the hypothalamus, we compared the expression of Sim1, Arnt, Arnt2, and Bmal1 in the newborn PVN/SON. The PVN lines the third ventricle at the most dorsal aspect of the anterior hypothalamus as illustrated in Fig. 1B ,C. Originating from the prospective PVN region, the SON neurons migrate to the lateral surface of the hypothalamus during development (Fig. 1B,C) . At birth, Arnt is expressed ubiquitously at very low levels in the brain without speci®c expression in the PVN or SON (data not shown). In contrast, much higher levels of Arnt2 expression are detected throughout the CNS, consistent with the results of Jain et al. (1998) . Importantly, we show here that increased expression of Arnt2 can be detected speci®cally in the PVN and SON, where Sim1 is also expressed (Fig. 1D ,E). Bmal1 expression is not detectable in the PVN and SON but instead is restricted to the SCN in this region of the hypothalamus (Jin et al., 1999 ; and data not shown). Since there is no available information speci®cally regarding Arnt2 expression in the developing hypothalamus, we next examined whether a high level of Arnt2 expression is also co-localized with the Sim1 domain at the initial stage of PVN and SON development. At E13.5, prior to the migration of SON cells, the prospective PVN/SON occupies the most dorsomedial aspect of the Sim1 domain (outlined in Fig. 1F ). Similar to what was observed in the newborn, Arnt2 expression is ubiquitous in the E13.5 brain and is clearly stronger in the region that coincides with the dorsomedial portion of the Sim1 domain (Fig. 1G) . At that stage, Arnt expression is detected generally in the brain at a low level and Bmal1 expression is not observed in the anterior hypothalamus (not shown). High level and persistent Arnt2 expression throughout the development of the PVN/SON raises the possibility that ARNT2 acts as the major partner of SIM1 during the development of the hypothalamus.
The PVN/SON fails to develop in c 112K homozygotes
In order to determine whether ARNT2 is the dimerization partner for SIM1 in the mouse, analysis of its function during PVN/SON development is required. A series of deletions encompassing the albino (c) locus was generated by irradiation in the mouse (Russell, 1952) . The Arnt2 gene was recently shown to map within the c 112K deletion and outside the overlapping c 3H deletion (Wines et al., 1998) (refer to Fig. 2E ). Mice homozygous for these deletions Fig. 1 . In vitro dimerization and co-expression of SIM1 and ARNT2. (A) Co-immunoprecipitation assay using in vitro translated ARNT, ARNT2, BMAL1, MYF5 and HA-tagged SIM1 (SIM1-HA) proteins. The in vitro translation products included in each reaction and the use of the anti-HA monoclonal antibody 12CA5 are indicated at the top of the panel by the`1' signs. The ®rst two lanes show that SIM1-HA protein can be immunoprecipitated by the anti-HA antibody. Due to the similarity in size between SIM1-HA and ARNT, SIM1-HA used in the co-immunoprecipitation reactions was not labeled (SIM1-HA cold). In the presence of SIM1-HA cold, the antibody can co-immunoprecipitate ARNT, ARNT2 and BMAL1 but not MYF5. (B) Coronal section of a wild-type newborn brain through the anterior hypothalamus stained with hematoxylin. The paraventricular nucleus (PVN), suprachiasmatic nucleus (SCN) and supraoptic nucleus (SON) can be distinguished on this section as indicated on the accompanying scheme (C). (D±G) Comparison of Sim1 (D,F) and Arnt2 (E,G) expression on adjacent coronal sections of newborn (D,E) and E13.5 (F,G) hypothalamus. In the newborn brain, Sim1 (D) is expressed in the PVN (outlined by red dashed lines and arrowhead) and in the SON (arrow) whereas Arnt2 (E) is expressed ubiquitously but more strongly in the PVN and in the SON. In the E13.5 brain, Sim1 (F) is expressed in the mantle zone at the level of the anterior hypothalamus in a domain (arrowhead on the right) that contains the prospective PVN/SON (outlined by red dashed lines on the left). The PVN/SON corresponds to the dorso-medial portion of the Sim1 domain. At this stage, Arnt2 is expressed ubiquitously but more strongly in the region that overlaps with the Sim1 dorso-medial domain (compare F and G). The asterisks in F and G indicate the lumen of the third ventricle.
have been shown to display liver dysfunction and die shortly after birth. This lethality was attributed to fumarylacetoacetate hydrolase (Fah) de®ciency (Grompe et al., 1993; Kelsey et al., 1993) . However, no neural defects associated with this deletion mutant have ever been reported. In view of the fact that Sim1 mutant mice display a PVN/SON defect and show perinatal lethality, it is possible that a hypothalamic defect also contributes to the death of c 112K homozygotes. Importantly, the c 112K mice allow us to assess the contribution of Arnt2 to PVN/SON development.
To test whether Arnt2 gene function is required for PVN/ SON development as suggested by its protein dimerization and RNA co-expression with Sim1, we examined the hypothalamus of c 112K homozygotes in which Arnt2 is deleted. Because c 112K homozygous mice die immediately after birth, we studied embryos collected at E18.5, one day before birth. Histological sections of E18.5 brains from c 112K homozygotes and control littermates revealed that both the PVN and SON are strikingly hypocellular in mutant embryos ( Fig. 2A,D) . No signi®cant change was observed in the mutant aPV, possibly because this nucleus is morphologically dif®cult to distinguish. Of note, the diameter of the third ventricle is increased in the mutant brain, as also found in Sim1 mutant animals.
In contrast to c 112K homozygotes, no alteration was detected in the PVN or SON of c 3H homozygotes (data not shown). The c 3H deletion overlaps with the c 112K but does not encompass a 350-kb interval that includes Arnt2 (refer to Fig. 2E ). These results demonstrate that the hypothalamus defects result solely from the loss of the 350-kb Arnt2 interval, and not from the loss of genes in the region of overlap between the c 3H and c 112K deletions. Importantly, the Arnt2 structural gene spans at least ten exons over half of the interval (Wines et al., 1998) , suggesting that the defects observed in c 112K mutant hypothalamus are due solely to the loss of Arnt2.
To further characterize the PVN/SON defect of c 112K homozygotes, we examined the magnocellular neurons by studying the production of AVP (Figs. 3A ,B and 4A,B) and the parvocellular neurons by studying the expression of Trh (Fig. 3C,D) , Crh (Fig. 3E,F) and SS (Fig. 3G,H) . SS is used here as a marker of the aPV. Consistent with our prediction that Sim1/Arnt2 co-expression re¯ects that they are partners in the hypothalamus, we were unable to detect the expression of these markers in the presumptive regions of the PVN, aPV and SON. Furthermore, Brn2, a gene encoding a POU transcription factor which acts downstream of Sim1 to direct the development of AVP-, OT-and CRH-producing cells of the PVN and SON (Nakai et al., 1995; Schonemann et al., 1995) , was also undetectable in these regions (Figs. 3I,J and 4C,D). The magnocellular neurosecretory system is composed of two major cell types which either produce AVP or OT. However, in the PVN/SON of normal day 18.5 embryos, the production of OT is barely detectable and therefore cannot be used as a reliable marker in our experiments. Nevertheless, the loss of expression of AVP and Brn2, which is normally expressed by both AVP-and OT-producing cells and is necessary for their development, allows us to conclude that the entire magnocellular system of c 112K homozygotes is affected. The loss of expression of Crh, Trh and SS indicates that at least three types of parvocellular neurons fail to develop in the mutants. We conclude that c 112K homozygotes show a PVN/SON/aPV phenotype identical to that observed in Sim1 mutant mice.
Consistent with these ®ndings, there is also no signi®cant Sim1 expression in the expected anatomical positions of the PVN, SON and aPV of c 112K homozygotes where its expres- sion is normally detected at E18.5 (compare Figs. 3K,L and 4E,F). Sim1 expression in other regions of the anterior hypothalamus (e.g. the ventral-lateral hypothalamus; data not shown) is maintained in c 112K mutant embryos. Some of these Sim1-expressing cells are derived from the ventral and lateral areas of the E13.5 Sim1 domain which do not show an increased Arnt2 expression (compare Fig. 1F and G). Intriguingly, an ectopic Sim1 domain is detected lateral to the presumptive PVN position (Fig. 3L) . At this point, we do not know the signi®cance of this domain (see discussion, Section 4).
Sim1 and Arnt2 control the same developmental processes
The above analyses together suggest that Arnt2 is responsible for the loss of the PVN/SON observed in the c 112K mutant. However, this ®nding does not imply that Arnt2 functions at the same stages or in the same pathway during development of the PVN/SON as does Sim1. In order to determine if this is indeed the case, we analyzed the initial stages of PVN/SON development in c 112K homozygous embryos.
Neurons of the prospective PVN/SON begin to express Sim1 when they migrate from the ventricular zone into the mantle zone, after having completed their division. We previously showed that these Sim1-expressing cells are generated in E13.5 Sim1 mutant embryos (as revealed by the expression of Sim1 mutant transcripts), but fail to terminally differentiate, suggesting that Sim1 controls the later stages of their differentiation (Michaud et al., 1998) . Analysis of c 112K homozygous embryos at E13.5, a stage when neurogenesis of the PVN/SON has been completed, revealed that the Sim1 expression domain in the hypothalamus was indistinguishable from that of control embryos (Fig. 5A,B) . This ®nding suggests that, as for Sim1, the loss of Arnt2 does not affect the generation or the early differentiation of the PVN/SON precursors but interferes with the later stages of their differentiation. The proper initiation of Sim1 expression in these mutant c 112K embryos also indicates that Arnt2 does not function upstream of Sim1. Conversely, Sim1 does not act upstream of Arnt2, as no signi®cant down regulation of Arnt2 expression is observed in the Sim1 mutant prospective PVN/SON (data not shown). In the absence of terminal differentiation, cells of the prospective PVN/SON cease to express Sim1 around E15.5 in both Sim1 and c 112K homozygotes, re¯ecting either cell death or a change of fate (Michaud et al., 1998 ; data not shown).
During development of the PVN/SON, Sim1 acts upstream of Brn2 which in turn controls the terminal stage of differentiation of AVP-, OT-and CRH-expressing cells (Michaud et al., 1998) . More speci®cally, Brn2 expression is activated within the ventricular zone but not maintained in the cells that migrate out to populate the prospective PVN/ SON region of E13.5 Sim1 mutant embryos where Sim1 mutant transcript is still detectable. In order to determine whether Arnt2 also functions upstream of Brn2, we examined the expression of Brn2 in E13.5 c 112K homozygous embryos. As shown in Fig. 5D , Brn2 expression is present in the ventricular zone but dramatically reduced or absent in the cells of the prospective PVN/SON of these mutant embryos. Therefore, not only are Sim1 and Arnt2 required at the same developmental stage, they also have the convergent function of maintaining the expression of Brn2. This observation strongly suggests that ARNT2 acts in parallel as the dimerization partner of SIM1 during the development of the PVN/SON.
Discussion
In Drosophila, Sim is a master neural regulator, necessary and suf®cient for the development of the midline cells of the central nervous system (CNS) (reviewed in Crews, 1998) . Heterodimerization with Tango, an ubiquitously expressed bHLH±PAS protein, is required for Sim transcriptional activity (Sonnenfeld et al., 1997) . Consistent with Tango's role as a general dimerization partner, it is also required for the function of other bHLH±PAS proteins (reviewed in Crews and Fan, 1999) . The CNS-speci®c function carried out by Sim/Tango is presumably due to the dimer context (e.g. their DNA recognition sequence) and the tissue-speci®c expression of Sim. We have shown here that SIM1, a mammalian homolog of Sim, can biochemically interact with the Tango homolog ARNT2. Although ubiquitously expressed in the CNS (Jain et al., 1998) , Arnt2 is speci®cally upregulated in the PVN/SON where Sim1 is co-expressed and functionally required. Importantly, mice de®cient in Arnt2 display the same hypothalamic defect as the one characterized in Sim1 mutant mice (Michaud et al., 1998) . Furthermore, expression of Sim1 and Arnt2 in the prospective PVN/SON is independent of each other. These ®ndings together strongly suggest that ARNT2 functions as the SIM1 dimerization partner to direct the development of the PVN/SON.
In vivo dimerization of the mammalian bHLH±PAS proteins
In the mouse, the three ARNT-like proteins appear to mediate strikingly distinct functions correlated with their expression patterns. ARNT is broadly expressed in the mesoderm and endoderm but only at a low level in the CNS (Jain et al., 1998) and can form a dimer with HIF-1a (Hogenesch et al., 1997) . Embryonic stem cells lacking either gene fail to mediate hypoglycemic and hypoxic response and mice homozygous for mutations in each gene display poor angiogenesis that is consistent with their defects in hypoxic response (Maltepe et al., 1997; Iyer et al., 1998) . Thus HIF-1a and ARNT most likely form functional heterodimers in vivo to mediate hypoxia response in the mesoderm. In contrast, Arnt2 expression is the reciprocal of Arnt, being strongly and ubiquitously expressed in the developing CNS but not in the mesoderm or endoderm (Jain et al., 1998) . SIM1 is the ®rst bHLH±PAS protein identi®ed to ful®ll the criteria of an ARNT2 in vivo partner. The fact that Sim1 is expressed in discrete regions of the CNS representing only a small subset of the tissues which express Arnt2 raises the possibility that the latter heterodimerizes with other bHLH±PAS proteins in other brain regions. For instance, ARNT2 may be the partner of NPAS1 and NPAS2 which are expressed in speci®c areas of the brain during development (Zhou et al., 1997) . It has also been proposed that ARNT2 may participate in the hypoxia response by forming functional heterodimers with HIF-1a in the neural tube (Maltepe et al., 1997) . Thus, the biochemical properties and broad expression patterns of ARNT and ARNT2 suggest that they act as general dimerization partners for bHLH±PAS proteins, a role similar to that played by E proteins for the classic bHLH transcription factors (reviewed by Jan and Jan, 1993) .
Distinct from Arnt and Arnt2, Bmal1, the third Arntrelated gene, has a very restricted expression pattern . Although no data on Bmal1 mutant mice are yet available, expression studies and cell transfection assays strongly suggest that BMAL1 dimerizes with CLOCK to regulate circadian gene expression in the SCN (Gekakis et al., 1998; Jin et al., 1999) . BMAL1 also differs from ARNT and ARNT2 in that it is more related to the Drosophila Cycle than to Tango (Rutila et al., 1998) . Cycle dimerizes with Clock, the ortholog of CLOCK, to control the circadian rhythm in the¯y. Thus, Cycle/Clock and BMAL1/CLOCK represent remarkably conserved functional dimer pairs during evolution. Similarly, the function of the dimerization pairs, SIM1/ARNT2 and Sim/Tango, in the development of the neuroendocrine system also appears to have been conserved. For instance, insect brain midline neurons whose formation may be governed by Sim include a number of neurosecretory and neuropeptide-producing cells including CRH-like diuretic peptides (Patel et al., 1994) , much like the cells types within the PVN/SON. 
Cell type speci®cation by SIM1 heterodimers
Although SIM1 can not utilize a functionally equivalent partner to compensate for the loss of ARNT2 in the PVN/ SON cells, it likely forms a functionally distinct complex with another bHLH±PAS protein(s) in other areas of the anterior hypothalamus, thereby expanding its repertoire of regulatory roles. Consistent with this prediction, only the dorsomedial area within the Sim1 hypothalamic domain (the prospective PVN/SON) coincides with the upregulated Arnt2 expression and is affected in Arnt2 de®cient mutants. These results suggest SIM1 does not utilize ARNT2 as its partner in the lateral and ventral regions of the hypothalamus. Because Arnt is weakly expressed and Bmal1 is not expressed in these areas, a yet to be unidenti®ed ARNTrelated protein may be involved in speci®cation of these regions.
Consistent with the possibility that SIM1 can heterodimerize with other bHLH±PAS proteins for different function, we observed that several areas of the anterior hypothalamus remain unaffected in c 112K mutants that are lost in the Sim1 mutant (Michaud and Fan, unpublished data) . Interestingly, we observed an ectopic domain of Sim1 expression in the anterior hypothalamus of c 112K mutant embryos (Fig. 3L) . The fact that this ectopic Sim1 domain is present in Arnt2 but not in Sim1 de®cient mice suggests that in the absence of ARNT2, SIM1 maintains its own expression and may respecify the cell fate through the formation of a functionally distinct heterodimer. In support of this prediction, sim function is required for maintaining its own transcription in the¯y and the CNS midline cells of the sim and tango mutants are transformed to become lateral CNS cells (S. Crews, pers. commun.).
A new phenotype for a classical mutant
Phenotypic characterization using overlapping genomic deletion is a powerful approach to rapidly characterize the function of a gene (Holdener-Kenny et al., 1992) . The deletions used in this study are part of a series of deletions encompassing the mouse albino (c) locus (Russell et al., 1979 (Russell et al., , 1982 . Wines et al. (1998) demonstrated that the c 112K deletion extends ,350 kb beyond the c 3H deletion and completely removes the entire ,170 kb Arnt2 structural gene (Fig. 2E) . The fact that the PVN/SON defect observed in c 112K mice is not present in c 3H mice allows us to map this trait to the 350-kb genomic region including Arnt2. Although it is formally possible that an as yet unidenti®ed gene located in the remaining ,150 kb is responsible for the hypothalamus defects, the demonstration of biochemical interactions between SIM1 and ARNT2, overlapping expression patterns, and similarity between the SIM1 and c 112K hypothalamus provide compelling evidence that the defects observed in c 112K mutant hypothalamus are due solely to the loss of Arnt2. c 112K mice have a complex developmental phenotype of which two elements are now explained. First, the liver dysfunction is assigned to Fah de®ciency (Grompe et al., 1993; Kelsey et al., 1993) . Second, the hypothalamic phenotype reported here can be attributed to the loss of Arnt2. The other developmental defects found in these mice are incompletely penetrant and include thymic hypoplasia (Erickson et al., 1968; Russell et al., 1982) and abnormalities typically associated with cardiac neural crest defects (DeRossi and Holdener, in preparation). Interestingly, Arnt2 has been shown to be expressed in the neural crest and in some of its derivatives (Jain et al., 1998) . However, it remains to be determined whether these defects are caused by the loss of Arnt2, and if so, what other bHLH±PAS proteins are involved in controlling the development of these tissues.
